Prefer NATO definitions---biotech in a military context is defined broadly
Melson ‘4 [Ashley; 2004; Associate, The Barkley Law Firm, PC. B.S. P.T., University of Oklahoma Health Sciences Center, 1997 and J.D., Valedictorian, University of Tulsa College of Law; “Bioterrorism, Biodefense, and Biotechnology in the Military: A Comparative Analysis of Legal and Ethical Issues in the Research, Development, and Use of Biotechnological Products on American and British Soldiers,” 14 Alb. L.J. Sci. & Tech. 497, lexis]
Biology, 1 one of the three primary natural sciences, like its counterpart sciences of chemistry and physics, uses the experimental method 3 Unlike its counterparts, however, the study of biology inherently involves living things, including human beings. 4 Because of this distinction, which implicates both human rights and the Hippocratic Oath, 5 the experimental method becomes legally and ethically unacceptable as a means of studying biology, at least when human subjects are involved. 6 Further, knowledge gleaned in this science does not truly come to fruition until applied and used in the real world through technological innovations, thus the term "biotechnology." 7
Although not officially defined until 1919 by Hungarian engineer, Karl Ereky, 8 the first example of biotechnological innovations noted in literature dates back well before Ereky's time to the selective breeding of livestock and growing of crops during the Agricultural Revolution. 9 Today, a sort of "biotechnological age" is being realized, 10 as the United States (U.S.) Government, alone, invested over $ 18 billion in biotechnology research and development (R&D) for fiscal year 2000. 11 This figure is dwarfed by the R&D budgets of large pharmaceutical companies and other commercial investors. 12
Beyond the financial investment in biotechnology is the investment from both individuals and society as a whole. Because the testing and use of biotechnological products inherently involves living organisms from microbes to human beings, 13 complex legal and ethical issues arise, the solutions to which have yet to be answered, and, at times, even addressed. Basic standards for research using human subjects have been enunciated in international instruments beginning with the Nuremberg Code, 14 but, as history has shown, the research context has often dictated whether such standards would apply, and to what extent, in actual practice. 15 Furthermore, research involving the use of human "materials," namely stem cells 17 raises perhaps even more controversial issues than human subject research. Once biotechnology products are developed, a new series of debates arises as to whether their use is appropriate, and, if so, by whom and for what purpose, 18 as well as what may be done with information obtained through the research or the use of biotechnology. 19
Ultimately, this question is presented: Do the benefits of biotechnology outweigh risks associated with these unresolved issues? The answer may depend on what stands to be lost if testing and use of biotechnology products is not pursued. In the public health context, these products provide potential solutions to pressing concerns in the national, as well as global, arena. Developments in genetically engineered foods and drugs, for example, pose alternatives to addressing issues of world hunger and disease. In the medical context, biotechnology products have revolutionized health care by providing new options for injury and illness prevention, as well as treatment, in the form of pharmaceuticals, procedures, and devices.
Also affected on a global scale and, perhaps, ever so evident with the recent threats of bioterrorism, are the opportunities biotechnology presents in the military context, 20 which is defined as "the exploitation and manipulation of biological systems to benefit overall military capability." 21 [21]Dr. Steve Nicklin, Medical Issues: The Future Impact of Biotechnology on Human Factors, in NATO Research & Technology Organization, RTO Meeting Proceedings 77: Human Factors in the 21st Century, RTO-MP-077 AC/323(HFM-062)TP/38 (2002), http://www.rta.nato.int/Abstracts.asp?Restrict Panel=HFM (last visited Mar. 20, 2004).[/21] According to a recent report by the Information Assurance Technology Analysis Center (IATAC), "history has shown that an infusion of technology can provide a significant military advantage to the side that first realizes its potential and exploits it." 22 However, the historical examples described, namely invention of the tank, development of U.S. naval aviation capabilities, and technologies emerging from the Information Revolution, fail to invoke the legal and ethical complexities presented by biotechnological research, development, and use in the military. Such concerns become particularly relevant in light of the history of abuse of civilian and service member subjects in research conducted or sponsored by the militaries of both the U.S. 23 and its European Ally, the United Kingdom (U.K.). 24